𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Paclitaxel/carboplatin as first line therapy in advanced (Stage IIIB/IV) NSCLC

✍ Scribed by Yaman, M; Tosun, G.A; Anakkaya, A.N; Erturan, S; Tutluoglu, B


Book ID
118569790
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
246 KB
Volume
29
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Second-line, low-dose, weekly paclitaxel
✍ Mark A. Socinski; Michael J. Schell; Kamal Bakri; Amy Peterman; Ji-Hyun Lee; Pau πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Second‐line chemotherapy with docetaxel improves survival and quality of life (QoL) in patients with nonsmall cell lung carcinoma (NSCLC) who fail first‐line platinum‐based regimens. The authors sought to determine the activity of second‐line, low‐dose, weekly paclitaxel